| BMI | Body mass index |
| C3 | Complement component 3 |
| CXCR3 | C-X-C chemokine receptor type 3 |
| ELISA | Enzyme-linked immunosorbent assay |
| FODMAP | Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HP | Haptoglobin |
| HP1 | Haptoglobin 1 allele |
| HP2 | Haptoglobin 2 allele |
| HP1-1 | Haptoglobin 1-1 genotype |
| HP2-1 | Haptoglobin 2-1 genotype |
| HP2-2 | Haptoglobin 2-2 genotype |
| IBD | Inflammatory bowel disease |
| IBS | Irritable bowel syndrome |
| IBS-C | Irritable bowel syndrome, constipation-predominant |
| IBS-D | Irritable bowel syndrome, diarrhoea-predominant |
| IBS-M | Irritable bowel syndrome, mixed |
| I-FABP | Intestinal fatty acid-binding protein |
| IP | Immunoprecipitation |
| IQR | Interquartile range |
| mAb | Monoclonal antibody |
| MyD88 | Myeloid differentiation primary response 88 |
| NCGS | Non-coeliac gluten sensitivity |
| NOS | Newcastle–Ottawa Scale |
| NR | Not reported |
| pre-HP2 | Pre-haptoglobin-2 |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| SD | Standard deviation |
| ZO-1 | Zonula occludens-1 |